Hemicrania continua (HC) is characterised by a strictly unilateral continuous headache with ipsilateral autonomic features and migrainous symptoms that is exquisitely sensitive to indomethacin.1 As more than 30% of patients report side effects with indomethacin, there is need for an effective and safe alternative. Although several drugs have been used in open-label studies, none offer the same magnitude of response. Occipital nerve stimulation (ONS) has been performed in headache conditions such as chronic migraine and chronic cluster headache, both conditions with clinical similarities to HC and appears to be a safe, potentially efficacious treatment even in those failing all available medical treatments.2 We report the long-term follow...
Background: About 10% of cluster headache patients have the chronic form. At least 10% of this chron...
Background. Drug-resistant chronic cluster headache (drCCH) is a devastating condition for which var...
BACKGROUND: A retrospective review of patients treated with Occipital Nerve Stimulation (ONS) at two...
SummaryMoura LMVR, Bezerra JMF, Fleming NRP – Treatment of Hemicrania Continua: Case Series and Lite...
BACKGROUND: Hemicrania continua is a strictly unilateral, continuous headache, typically mild to ...
Hemicrania continua is a strictly unilateral, continuous headache, typically mild to moderate in sev...
Occipital nerve stimulation (ONS) has been employed off-label for medically refractory head pain. Id...
Hemicrania continua (HC) is a primary chronic headache disorder, characterized by a continuous and s...
Background and objectives: Hemicrania Continua (HC) is a primary, disabling headache characterized b...
A proportion of chronic headache patients become refractory to medical treatment and severely disabl...
Chronic daily headache is a major worldwide health problem that affects 3–5% of the population and r...
BACKGROUND: Occipital nerve stimulation is a potential treatment option for medically intractable sh...
Hemicrania continua (HC) and new daily-persistent headache (NDPH) represent the only two forms of ch...
Background About 10% of cluster headache patients have the chronic form. At least 10% of this chroni...
Chronic paroxysmal hemicrania (CPH) is a rare primary headache syndrome, which is classified along w...
Background: About 10% of cluster headache patients have the chronic form. At least 10% of this chron...
Background. Drug-resistant chronic cluster headache (drCCH) is a devastating condition for which var...
BACKGROUND: A retrospective review of patients treated with Occipital Nerve Stimulation (ONS) at two...
SummaryMoura LMVR, Bezerra JMF, Fleming NRP – Treatment of Hemicrania Continua: Case Series and Lite...
BACKGROUND: Hemicrania continua is a strictly unilateral, continuous headache, typically mild to ...
Hemicrania continua is a strictly unilateral, continuous headache, typically mild to moderate in sev...
Occipital nerve stimulation (ONS) has been employed off-label for medically refractory head pain. Id...
Hemicrania continua (HC) is a primary chronic headache disorder, characterized by a continuous and s...
Background and objectives: Hemicrania Continua (HC) is a primary, disabling headache characterized b...
A proportion of chronic headache patients become refractory to medical treatment and severely disabl...
Chronic daily headache is a major worldwide health problem that affects 3–5% of the population and r...
BACKGROUND: Occipital nerve stimulation is a potential treatment option for medically intractable sh...
Hemicrania continua (HC) and new daily-persistent headache (NDPH) represent the only two forms of ch...
Background About 10% of cluster headache patients have the chronic form. At least 10% of this chroni...
Chronic paroxysmal hemicrania (CPH) is a rare primary headache syndrome, which is classified along w...
Background: About 10% of cluster headache patients have the chronic form. At least 10% of this chron...
Background. Drug-resistant chronic cluster headache (drCCH) is a devastating condition for which var...
BACKGROUND: A retrospective review of patients treated with Occipital Nerve Stimulation (ONS) at two...